Volker Neugebauer, MD, PhD, will use the grant from the National Institute of Neurological Disorders and Stroke to understand a process that causes hyperactivity in the amygdale and leads to persistent pain and anxiety.
Related Articles on Pain Management:
Convergence Pharmaceuticals Neuropatic Pain Drug Completes Phase I Trials
Trial for Boston Scientific’s Spinal Cord Stimulation Device Shows Promising Results
Oregon House Co-Speaker Visits Middle Fork Surgery Center for Pain Management Policy Discussion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.